Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Clinical trial NCT02658968 · COMPLETED

Trial details

NCT number: NCT02658968
Sponsor: Nordic Nanovector
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed, Diffuse Large B-cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma

Start date: 2017-03-02
Primary completion: 2021-06-04
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.